182 related articles for article (PubMed ID: 35305239)
1. Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center.
Hellgren LS; Stenman A; Paulsson JO; Höög A; Larsson C; Zedenius J; Juhlin CC
Endocr Pathol; 2022 Jun; 33(2):231-242. PubMed ID: 35305239
[TBL] [Abstract][Full Text] [Related]
2. High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma.
Mu N; Juhlin CC; Tani E; Sofiadis A; Reihnér E; Zedenius J; Larsson C; Nilsson IL
Endocrine; 2018 Aug; 61(2):293-302. PubMed ID: 29796987
[TBL] [Abstract][Full Text] [Related]
3. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
Sanii S; Saffar H; Tabriz HM; Qorbani M; Haghpanah V; Tavangar SM
Asian Pac J Cancer Prev; 2012; 13(5):2175-8. PubMed ID: 22901190
[TBL] [Abstract][Full Text] [Related]
5. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
Thompson LDR
Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
[TBL] [Abstract][Full Text] [Related]
6. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: risk stratification of thyroid follicular cell carcinomas.
Kakudo K; Wakasa T; Ohta Y; Yane K; Ito Y; Yamashita H
Endocr J; 2015; 62(1):1-12. PubMed ID: 25195708
[TBL] [Abstract][Full Text] [Related]
7.
Paulsson JO; Mu N; Shabo I; Wang N; Zedenius J; Larsson C; Juhlin CC
Endocr Relat Cancer; 2018 Jul; 25(7):723-733. PubMed ID: 29692346
[TBL] [Abstract][Full Text] [Related]
8. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
[TBL] [Abstract][Full Text] [Related]
9. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
Aiad HA; Bashandy MA; Abdou AG; Zahran AA
Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.
Ito Y; Hirokawa M; Miyauchi A; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Kobayashi K; Miya A
Endocr J; 2016 Oct; 63(10):913-917. PubMed ID: 27432822
[TBL] [Abstract][Full Text] [Related]
11. A PCR-based expression signature of malignancy in follicular thyroid tumors.
Foukakis T; Gusnanto A; Au AY; Höög A; Lui WO; Larsson C; Wallin G; Zedenius J
Endocr Relat Cancer; 2007 Jun; 14(2):381-91. PubMed ID: 17639052
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
Ito Y; Hirokawa M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A; Miyauchi A
Endocr J; 2021 Aug; 68(8):881-888. PubMed ID: 33746136
[TBL] [Abstract][Full Text] [Related]
13. Mutation profiles of follicular thyroid tumors by targeted sequencing.
Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
[TBL] [Abstract][Full Text] [Related]
14. Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
Hirokawa T; Arimasu Y; Nakazato Y; Chiba T; Fujiwara M; Kamma H
Pathol Int; 2020 Apr; 70(4):210-216. PubMed ID: 31943533
[TBL] [Abstract][Full Text] [Related]
15. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
16. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
[TBL] [Abstract][Full Text] [Related]
17. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.
Cerutti JM; Delcelo R; Amadei MJ; Nakabashi C; Maciel RM; Peterson B; Shoemaker J; Riggins GJ
J Clin Invest; 2004 Apr; 113(8):1234-42. PubMed ID: 15085203
[TBL] [Abstract][Full Text] [Related]
18. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of NRAS(Q61R) protein in follicular-patterned thyroid tumors.
Oishi N; Kondo T; Vuong HG; Nakazawa T; Mochizuki K; Kasai K; Inoue T; Tahara I; Hirokawa M; Miyauchi A; Katoh R
Hum Pathol; 2016 Jul; 53():51-7. PubMed ID: 26980032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]